SIG
DXCM icon

Stanford Investment Group’s DexCom DXCM Stock Holding History

Stanford Investment Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,296
Closed -$19K – 78
2016
Q4 		$19K Buy
1,296
+772
+147% +$13.7K 0.01% 257
2016
Q3 		$11K Buy
+524
New +$11.7K 0.01% 306

Other funds holding DXCM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Stanford Investment Group's DXCM Position: Q1 2017 in Review

Stanford Investment Group sold out of DexCom (DXCM) in Q1 2017, closing a stake of 1,296 shares — an estimated $19K sold.

Stanford Investment Group first reported a position in DXCM in Q3 2016 and held it in 2 quarters. The position peaked at $19K in Q4 2016. 321 funds tracked by Wall St. Rank hold DXCM as of Q1 2017.

  • Stanford Investment Group reported no remaining DexCom position as of Q1 2017 after selling out during the quarter.
  • Stanford Investment Group sold 1,296 DexCom shares in Q1 2017, an estimated $19K.
  • Stanford Investment Group first reported a position in DexCom in Q3 2016 and held it in 2 quarters.
  • Stanford Investment Group's DexCom position peaked at $19K in Q4 2016.
  • 321 funds tracked by Wall St. Rank held DexCom as of Q1 2017.

Based on Stanford Investment Group's 13F filing for Q1 2017.